XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.23.3

Commitments and Contingencies | 9 Months Ended
--- | ---
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract] |
Commitments and Contingencies | Note 7. Commitments and Contingencies Operating Leases The Company leases its office facilities, located in Concord, California and Amersfoort, the Netherlands, and certain equipment and automobiles under non-cancelable operating leases with initial terms in excess of one year that require the Company to pay operating costs, property taxes, insurance and maintenance. The operating leases expire at various dates through 2030, with certain of the leases providing for renewal options, provisions for adjusting future lease payments based on the consumer price index, and the right to terminate the lease early. The Company does not assume renewals in determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. The Company recorded the lease right-of-use asset and obligation at the present value of lease payments over the lease term. The rates implicit in the Company’s leases are generally not readily determinable. The Company must estimate its incremental borrowing rate to discount the lease payments to present value. Operating lease assets also include lease incentives. The Company reduced its office space and ceased using approximately 15,000 square feet of rentable area of corporate office building during the third quarter of 2023. The Company recognized a loss of $1.6 million related to this facilities consolidation in the three months ended September 30, 2023 in “Restructuring” on the Company’s condensed consolidated statements of operations. Supplemental cash flow information related to operating leases is as follows (dollars in thousands):
|  | Nine Months Ended |
|  | September 30, |
|  | 2023 |  |  | 2022 |
Cash payments for operating leases |  | $ | 3,257 |  |  | $ | 2,491 |
Right-of-use assets obtained in exchange for operating lease obligations |  |  | 1,099 |  |  |  | 1,354 |
|  | Nine Months Ended |
| September 30, |
|  | 2023 |  |  | 2022 |
Weighted-average remaining lease term |  |  | 5.7 |  |  | 6.7 years |
Weighted-average discount rate |  |  | 8.6 | % |  |  | 8.4 | %
Future minimum non-cancelable payments under operating leases as of September 30, 2023, were as follows (in thousands):
|  |  | Operating Leases |
2023 (remainder) |  |  | $ | 886 |
2024 |  |  |  | 3,472 |
2025 |  |  |  | 3,100 |
2026 |  |  |  | 3,085 |
2027 |  |  |  | 3,382 |
Thereafter |  |  |  | 7,420 |
Total future lease payments |  |  | $ | 21,345 |
Less imputed interest |  |  |  | 4,994 |
Present value of lease liabilities (1) |  |  | $ | 16,351 |
(1) Lease liabilities include those operating leases that we plan to sublease as a part of our facilities consolidation restructuring efforts. See Note 5 for additional information of restructuring. The operating lease expense for the three and nine months ended September 30, 2023 and 2022, were as follows (in thousands):
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Operating lease expense |  | $ | 877 |  |  | $ | 837 |  |  | $ | 2,595 |  |  | $ | 2,406 |
As of September 30, 2023, the Company had no leases that have not yet commenced. Purchase Commitments The Company is party to agreements with certain providers for certain components of the INTERCEPT Blood System. Certain of these agreements require minimum purchase commitments from the Company. As of September 30, 2023, the Company had $12.1 million of short-term purchase commitments and $5.5 million of long-term purchase commitments, which are not recorded in the Company’s condensed consolidated balance sheets.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//450/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//440/tableOfContent + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration